Method for detecting bile acid in serum
By using ammonia water-ammonium acetate-water + acetonitrile mobile phase system and solid-phase extraction optimization scheme in liquid chromatography tandem mass spectrometry detection, the problem of low resolution of bile acid isomers was solved, and the system pipe cleaning was extended The equipment life is improved and the accuracy and stability of detection are improved.
Patent Information
- Application Number
- CN202410937439.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-12
- Publication Date
- 2024-11-05
AI Technical Summary
The prior art has problems with low resolution and poor separation effect when detecting isomers of bile acids in serum, and high concentration of salts leads to contamination of chromatographic columns and instruments during detection, reducing the service life of the detection equipment.
The liquid chromatography tandem mass spectrometry detection was performed using ammonia water-ammonium acetate-water + acetonitrile mobile phase system, and combined with solid phase extraction and system pipeline cleaning scheme, the concentration and composition of the mobile phase and cleaning liquid phase were optimized to achieve accurate separation of bile acids. and quantitative to avoid system contamination.
It realizes the accurate separation and quantification of various bile acid isomers in the serum, extends the service life of the detection equipment and chromatographic columns, and improves the accuracy and stability of the detection.
Smart Images

Figure CN118897022A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of component detection, and more specifically, relates to a batch stable detection method for multiple bile acids in serum. Background Art
[0002] Bile acids (BAs) are the main components of bile and are a general term for a class of bile acids. They are produced by cholesterol metabolism in the liver and exist in the form of sodium or potassium salts. Bile acids are important regulators of life activities, participating in the regulation of glucose, lipid and energy metabolism, and are closely related to intestinal hormones, microbiota and energy balance. The circulation and metabolism of bile acids are closely related to organs such as the liver, gallbladder, intestines, and stomach. Bile acid circulation disorders will cause changes in bile acids in the body and the accumulation of toxic bile acids. Therefore, accurate detection of bile acids can help prevent and treat a variety of diseases such as cholestasis, bile duct infarction, hepatitis, cirrhosis, liver cancer, irritable bowel syndrome, etc.
[0003] As an endogenous metabolite, bile acid is diverse and has multiple compound forms, including cholic acid and chenodeoxycholic acid as primary bile acids, deoxycholic acid and lithocholic acid as secondary bile acids, glycosyl and taurine-bound metabolites, etc. At present, the detection of bile acid is mainly carried out by detecting the total serum bile acid level through enzyme-linked immunosorbent assay and other methods, but it can only reflect the total bile acid level. Liquid chromatography-tandem mass spectrometry (LC-MS / MS) can accurately detect the content of various types of bile acids due to its high sensitivity and specificity in distinguishing structural analogs, reflecting the changes in the levels of bile acid components under different disease states or treatment stages.
[0004] However, due to the large number of bile acid metabolites, the structures of different metabolites are similar, and there are multiple groups of isomers. At present, the mass spectrometry detection of bile acid spectra at home and abroad has the problems of low isomer separation and unsatisfactory separation effect, and the overall separation time of the target is long, the baseline is high, and the matrix interference is serious, which affects the accuracy of the test results. Ursodeoxycholic acid (DUCA) in the bile acid spectrum is a natural hydrophilic bile acid, accounting for 3% to 5% of the physiological bile acid in the human body. It is also the first choice for the clinical treatment of cholestasis. However, ursodeoxycholic acid has a variety of structural analogs that interfere, and it is difficult to effectively separate the analogs in the detection method, which affects the accuracy of the test results. As a result, the current clinical reference values for ursodeoxycholic acid are uneven. Effective separation of interference and accurate detection are problems that need to be solved urgently.
[0005] In addition, in mass spectrometry detection of bile acids, the conventional sample processing method uses protein precipitation, which is relatively fast, but has problems such as insufficient impurity removal, serious matrix interference, and huge pressure on the detection system. A small number of methods use solid phase extraction (SPE) to remove the influence of endogenous impurities. Generally, a high-concentration aqueous phase is used for elution, combined with a high-concentration organic phase for elution to avoid the loss of the target and effectively extract the target. However, the transition between the high-concentration aqueous phase and the organic phase leads to a long nitrogen blowing step, which is not conducive to the efficiency of batch detection.
[0006] In addition, as an endogenous substance, bile acid has many impurity interferences. How to effectively eliminate interference and maintain the stability of the method performance in large-scale clinical specimen testing has become one of the difficulties in overcoming the LC-MS / MS method for detecting bile acid. Conventional LC-MS / MS methods for detecting bile acid usually add 5-15mmol / l ammonium acetate and other high-concentration salts to the mobile phase to improve the detection effect of bile acid. However, large-scale testing will cause high-concentration salts to precipitate inside the detection instrument pipeline or in the chromatographic column, which will cause long-term contamination and blockage of the chromatographic column and instrument pipeline, reducing the service life of the chromatographic column and instrument; and after large-scale sample testing, it is easy to cause contamination of the chromatographic column and the detection instrument, resulting in elevated baselines, abnormal peak shapes, and decreased detection sensitivity, resulting in poor method reproducibility and affecting detection efficiency.
[0007] Therefore, there is an urgent need for a method that can simultaneously and accurately detect multiple bile acid isomers in serum and can improve the service life of detection equipment and chromatographic columns. Summary of the invention
[0008] Based on this, the object of the present invention is to provide a method for detecting bile acid in serum. By adopting this detection method, multiple bile acid isomers in serum can be detected simultaneously, and the accumulation of high-concentration salt in the mobile phase system in the instrument pipeline or chromatographic column in large-scale detection can be avoided, thereby improving the accuracy and stability of detection and extending the service life of detection equipment and chromatographic columns.
[0009] The technical solutions for achieving the above-mentioned invention objectives include the following.
[0010] The present invention provides a method for detecting bile acid in serum, comprising the following steps: cleaning a system pipeline of a liquid chromatography tandem mass spectrometer; performing liquid chromatography tandem mass spectrometry detection on a pretreated serum sample to be tested; in the liquid chromatography tandem mass spectrometry detection, a mobile phase A of the liquid chromatography is: an 8-12 mM ammonium acetate aqueous solution containing 0.03-0.08% ammonia water, and a mobile phase B is: an 8-12 mM ammonium acetate acetonitrile solution containing 0.03-0.08% ammonia water.
[0011] The detection method of the present invention selects a specific mobile phase, a substance added to the mobile phase, and the concentration of the substance added to the mobile phase in the liquid chromatography detection, and combines the cleaning scheme of the system pipeline of the liquid chromatography tandem mass spectrometry. Under this conception, the separation of multiple bile acid isomers in serum can be achieved, accurate quantification can be achieved, and detection time can be saved; and while ensuring the stability of the system, the residues of crystalline salts and endogenous impurities that may be precipitated and the system contamination caused by batch detection can be removed, and the phenomenon of system contamination caused by batch detection can be avoided, and the service life of the chromatographic column can be significantly improved, and the accuracy and stability of the detection can be improved; the detection method of the present invention has broad application prospects in the detection of large quantities of clinical specimens. BRIEF DESCRIPTION OF THE DRAWINGS
[0012] Figure 1 It is the liquid chromatogram of DCA and CDCA in Example 2 of the present invention.
[0013] Figure 2 It is the liquid chromatogram of GDCA and GCDCA in Example 2 of the present invention.
[0014] Figure 3 It is the liquid chromatogram of TDCA and TCDCA in Example 2 of the present invention.
[0015] Figure 4 This is the bile acid separation spectrum detected using an ammonia-ammonium acetate-water+acetonitrile mobile phase system in Example 3 of the present invention.
[0016] Figure 5 The separation spectra of DCA and CDCA detected by using formic acid-water / acetonitrile, formic acid+ammonium acetate-water / acetonitrile, ammonium acetate-water / acetonitrile and ammonia water+ammonium acetate-water / acetonitrile mobile phase systems in Example 3 of the present invention respectively.
[0017] Figure 6 The separation spectra of DCA and CDCA (A and B), and the separation spectra of UDCA and the interference peak (C, D and E) are shown when different concentrations of ammonia water are added to ammonium acetate in Example 3 of the present invention.
[0018] Figure 7 This is a liquid chromatogram of the system after being cleaned using the conventional cleaning solution in Example 5 of the present invention.
[0019] Figure 8 This is a liquid chromatogram of the system after being cleaned using the cleaning scheme of the present invention in Example 5 of the present invention. DETAILED DESCRIPTION
[0020] In order to facilitate the understanding of the present invention, the present invention will be described more fully below. The present invention can be implemented in many different forms and is not limited to the embodiments described herein. On the contrary, the purpose of providing these embodiments is to make the understanding of the disclosure of the present invention more thorough and comprehensive.
[0021] Unless otherwise defined, all technical and scientific terms used in the present invention have the same meaning as those commonly understood by those skilled in the art to which the present invention belongs. The terms used in the specification of the present invention are only for the purpose of describing specific embodiments and are not intended to limit the present invention. The term "and / or" used in the present invention includes any and all combinations of one or more of the related listed items.
[0022] The experimental methods in the following examples without specifying specific conditions are usually carried out under conventional conditions or conditions recommended by the manufacturers. The various commonly used chemical reagents used in the examples are all commercially available products.
[0023] Bile acid targets have similar structures and similar chemical properties. There are multiple isomers in the human body. Because isomers have the same ion pairs, they cannot be distinguished by mass spectrometry, so they need to be separated on the chromatography. However, the current detection scheme is very difficult to perform chromatographic separation on multiple bile acids. Insufficient separation of isomers and insufficient separation effect will affect the accurate quantification of the detection. The present invention explores the chromatographic conditions of liquid chromatography, especially the types and concentrations of mobile phases and additives in the mobile phase, and finds that only by using ammonia-ammonium acetate-water + acetonitrile mobile phase system for detection can the chromatographic separation of multiple groups of bile acid isomers be effectively achieved, and when the ammonia concentration is between 0.025% and 0.08%, the target index and the interference peak can be well separated, thereby ensuring the chromatographic separation of isomers, realizing the dual separation of chromatography and mass spectrometry of various bile acid isomers, and achieving accurate quantification.
[0024] Furthermore, the present invention optimizes the solid phase extraction (SPE) scheme. In the process of solid phase extraction (SPE) of the serum sample to be tested, the inventor found that after rinsing the SPE plate with deionized water, the solution at the bottom of the SPE plate was first dried with absorbent paper, and then centrifuged and eluted with methanol for nitrogen blowing, which can ensure the retention of the target while quickly removing water and greatly shorten the time of the SPE nitrogen blowing step.
[0025] In addition, the inventors of the present invention found that when cleaning the pipelines of the liquid chromatography-tandem mass spectrometry system, using low-concentration methanol (10%-18%), high-concentration methanol (90%-100%), high-concentration isopropanol (75%-85% isopropanol), and high-concentration methanol (90%-100%) to clean the system pipelines in sequence can ensure the stability of the system while removing the residues of crystalline salts and endogenous impurities that may be precipitated, avoiding system contamination caused by batch testing, and significantly improving the service life of the chromatographic column; compared with the currently commonly used pipeline cleaning schemes, as well as other cleaning reagents or other cleaning reagent concentrations, when the system cleaned using the cleaning scheme of the present invention is tested on samples, there is no peak bifurcation phenomenon, the peak shape is better and the response is higher, and it can be more accurately quantified, and the performance is stable in large-scale clinical specimen testing.
[0026] In some embodiments of the present invention, a method for detecting bile acid in serum is disclosed, comprising the following steps:
[0027] (1) Cleaning the system pipelines of liquid chromatography tandem mass spectrometry;
[0028] (2) The pretreated serum sample to be tested is subjected to liquid chromatography tandem mass spectrometry detection; in the liquid chromatography tandem mass spectrometry detection, the mobile phase A of the liquid chromatography is: 8-12 mM ammonium acetate aqueous solution containing 0.025-0.08% ammonia water, and the mobile phase B is: 8-12 mM ammonium acetate acetonitrile solution containing 0.025-0.08% ammonia water. The use of ammonia water-ammonium acetate-water / acetonitrile mobile phase system for detection can effectively achieve chromatographic separation of multiple groups of bile acid isomers.
[0029] In some of the embodiments, the volume concentration of aqueous ammonia in the mobile phase A and the mobile phase B is 0.04% to 0.06%. At this concentration, the target index and the interference peak can be better separated.
[0030] In some embodiments, the pretreatment in step (2) includes the following steps: adding an internal standard precipitant to the serum sample to be tested, then adding PBS buffer, centrifuging to obtain the supernatant; then performing solid phase extraction on the supernatant, centrifuging to obtain the supernatant, and filtering.
[0031] In some embodiments, the solid phase extraction comprises the following steps: eluting with water, absorbing the residual droplets at the bottom with absorbent paper, centrifuging, eluting with methanol and then blowing with nitrogen. Compared with direct methanol elution and nitrogen blowing after eluting, the present invention adds the steps of absorbing with absorbent paper + centrifugation before methanol elution, which can effectively shorten the nitrogen blowing time.
[0032] In some embodiments, the nitrogen blowing time is 65 to 75 minutes.
[0033] In some embodiments, the centrifugal speed is 2500-3500 rpm, and the centrifugal time is 4-6 min.
[0034] In some embodiments, the liquid chromatography further comprises: a chromatographic column using a Phenomenex KinetexEVO C18 chromatographic column.
[0035] In some embodiments, the elution procedure of the liquid chromatography is: 0.1 min, mobile phase B 25%; 4.5 min, mobile phase B 33%; 7.0 min, mobile phase B 99%; 8.5 min, mobile phase B 25%.
[0036] In some of the embodiments, in step (1), 10% to 18% methanol, 90% to 100% methanol, 75% to 85% isopropanol and 90% to 100% methanol are used in sequence to clean the system pipeline of the liquid chromatography tandem mass spectrometry.
[0037] In some of the embodiments, in step (1), 14% to 16% methanol, 94% to 96% methanol, 79% to 81% isopropanol and 94% to 96% methanol are used in sequence to clean the system pipeline of the liquid chromatography tandem mass spectrometry.
[0038] The present invention is described in detail below with reference to the accompanying drawings and specific embodiments.
[0039] Example 1 Detection method of bile acid in serum
[0040] This embodiment provides a method for detecting multiple bile acids in serum, comprising the following steps:
[0041] 1. Sample processing
[0042] 1. Preprocessing
[0043] Take 100 μL of the serum sample to be tested, add 100 μL of mixed isotope internal standard (precipitant), shake and mix, add 1 mL of PBS buffer, shake and mix, centrifuge, and take the supernatant;
[0044] 2. Solid Phase Extraction (SPE)
[0045] The SPE plate was activated by adding methanol, balanced by adding water, and then 1 ml of pre-treated sample was loaded, rinsed with 1 ml of deionized water, and the bottom solution was dried with absorbent paper, centrifuged at 3000 rpm for 5 min, eluted with 800 μL of methanol, blown with nitrogen for 70 min, re-dissolved with 800 μL of methanol, and centrifuged to obtain the supernatant;
[0046] 3. Filter
[0047] Take 95 μL of the supernatant from step 2 and transfer it to an Angla filter plate (0.22 μm), centrifuge at 3000 rpm for 5 min, and take the filtrate.
[0048] 2. Cleaning the LC-MS system
[0049] The liquid chromatography-tandem mass spectrometry system was cleaned using the following cleaning solutions and cleaning speeds (85% water-15% methanol, 0.3 min / mL, 30 min-95% methanol, 0.4 min / mL, 20 min-80% isopropanol-20% water, 0.2 min / mL, 30 min-95% methanol, 0.4 min / mL, 15 min).
[0050] 3. Liquid chromatography detection
[0051] Take 90 μL of the filtrate from step 1 and load it onto the machine for testing.
[0052] 1. Liquid phase conditions
[0053] The chromatographic column used was Phenomenex Kinetex EVO C18 column;
[0054] Mobile phase A (aqueous phase): an aqueous solution containing 0.05% ammonia and 10 mM ammonium acetate
[0055] Mobile phase B (organic phase): acetonitrile containing 0.05% ammonia and 10 mM ammonium acetate
[0056] The column temperature was 40°C, the injector temperature was 15.0°C, and the injection volume was 5 μL.
[0057] The elution gradient is shown in Table 1.
[0058] Table 1
[0059] step Analysis time (min) Flow rate (mL / min) Mobile phase B% Mobile phase A% 1 0.1 0.2 25 75 2 4.5 0.2 33 67 3 7.0 0.2 99 1 4 8.5 0.2 25 75
[0060] 2. Mass spectrometry conditions
[0061] An electrospray ion source (ESI) was used in negative ion mode and multiple reaction monitoring mode (MRM). The specific mass spectrometry conditions are shown in Table 2, and the source parameters are shown in Table 3.
[0062] Table 2
[0063]
[0064]
[0065] Table 3
[0066] Ionsprayvoltage(V) Gas1(psi) Gas2(psi) Temp(℃) CurtainGas(psi) Collision Gas (psi) -4500 35.0 35.0 550.0 20.0 9
[0067] Example 2 Methodological verification of the detection method of the present invention
[0068] 1. Linear range
[0069] The detection method of Example 1 of the present invention was used to perform standard curve detection, and two standard curves were detected every day for 3 consecutive days. The results are shown in Table 4.
[0070] Table 4
[0071] Compound Average recovery rate (%) Detection value CV (%) <![CDATA[Linear correlation coefficient R 2 > CA 95.68~108.63 4.59~8.28 0.99637 DCA 96.69~108.93 3.55~9.78 0.99610 CDCA 90.15~110.82 2.21~10.25 0.99402 UDCA 92.10~106.19 3.17~7.60 0.99569 LCA 93.20~107.14 2.39~9.48 0.99700 GCA 94.41~108.67 4.33~9.80 0.99371 TCA 94.62~106.32 2.69~8.47 0.99690 GDCA 98.15~102.88 5.02~8.31 0.99704 GCDCA 96.73~103.31 2.91~10.94 0.99672 GUDCA 95.35~106.9 2.52~9.00 0.99761 TDCA 93.47~103.48 7.34~10.88 0.99556 TCDCA 93.90~105.83 2.7~9.56 0.99497 TUDCA 95.30~107.20 4.16~9.90 0.99592 GLCA 89.51~104.94 6.85~10.66 0.99375 TLCA 95.44~105.52 2.39~8.72 0.99776
[0072] The results in Table 4 show that the linearity is good and the correlation coefficient R 2 >0.99, and the recovery rate is between 85.0% and 115.0%, which meets the requirements of clinical quantitative detection.
[0073] 2. Precision
[0074] In one batch, 20 serum samples at three concentration levels, low, medium and high, were processed in parallel, and each sample was injected once to verify the precision of the method of the present invention. The results are shown in Table 5.
[0075] Table 5
[0076]
[0077]
[0078] From the results in Table 5, it can be seen that the precision of the method of the present invention is good, and the precision CV is between 1.86% and 8.78%. The precision of the present invention can be controlled within <9% by optimizing solid phase extraction SPE, system cleaning method and liquid chromatography conditions.
[0079] 3. Accuracy
[0080] Mixed clinical samples of low, medium and high concentrations were collected, and homologous standard solutions of low, medium and high concentrations were added to perform spike recovery experiments to verify the accuracy of the method of the present invention. Three samples were processed in parallel, and the recovery of the spiked sample results was calculated. The results are shown in Table 6.
[0081] Table 6
[0082]
[0083]
[0084] The results in Table 6 show that the recoveries are all in the range of 88.53% to 107.55%, meeting the requirements.
[0085] 4. Separation of isomers
[0086] When using chromatography-mass spectrometry to detect multiple bile acid substances, due to the existence of multiple isomers, similar structures and close chemical properties, the chromatographic peaks are often close. If the isomers are not well separated, it will often interfere with the accuracy of the test results. There are 3 groups of isomers among the 15 test targets, namely DCA, UDCA and CDCA; GDCA, GCDCA and GUDCA; TDCA, TCDCA and TUDCA. Among them, the chromatographic peaks of DCA and CDCA, GDCA and GUDCA, TDCA and TCDCA are closest to each other.
[0087] The clinical samples were tested using the method of Example 1 of the present invention, and the separations of DCA and CDCA, GDCA and GUDCA, and TDCA and TCDCA were calculated according to the separation calculation formula.
[0088]
[0089]
[0090]
[0091] The peak width of the two adjacent peaks
[0092] The liquid chromatography of DCA and CDCA, GDCA and GUDCA, TDCA and TCDCA were as shown in Figure 1 to Figure 3 As shown, according to Figure 1 to Figure 3 The liquid chromatogram was obtained and the separation was calculated. The results showed that the separations of DCA and CDCA, GDCA and GUDCA, and TDCA and TCDCA were 3.15, 2.85, and 2.80, respectively, which were all greater than the separation required for conventional detection (1.5). This proves that the detection method of the present invention can ensure the chromatographic separation of the three groups of isomers, thereby achieving accurate quantification.
[0093] Example 3 Effect of mobile phase system on bile acid separation
[0094] 1. Different mobile phase systems
[0095] This example investigates the separation effect of bile acid substances in liquid chromatography tandem mass spectrometry under different liquid chromatography mobile phase systems. The method of Example 1 was used to detect clinical samples using different mobile phase systems (see Table 7). The results are shown in Table 7. Figure 4 and Figure 5 shown.
[0096] Table 7
[0097] Phase A Phase B Solution 1 0.05% Formic acid-water 0.05% Formic acid-acetonitrile Solution 2 10 mM ammonium acetate-water 10 mM ammonium acetate-acetonitrile Solution 3 0.05% Formic acid-10 mM Ammonium acetate-water 0.05% formic acid-10 mM ammonium acetate-acetonitrile Solution 4 0.05% ammonia-10 mM ammonium acetate-water 0.05% ammonia-10 mM ammonium acetate-acetonitrile
[0098] Figure 4 and Figure 5The results showed that the mobile phase system of scheme 4 (ammonia-ammonium acetate-water + acetonitrile) could effectively achieve the chromatographic separation of multiple groups of bile acid isomers ( Figure 4 as well as Figure 5 D in the above), while the mobile phase systems of schemes 1 to 3 (formic acid-water + acetonitrile, formic acid-ammonium acetate + acetonitrile, ammonium acetate-water + acetonitrile) were used for detection, there were a large number of overlapping chromatographic peaks, and chromatographic separation could not be achieved (see respectively). Figure 5 A, B, C in the figure).
[0099] 2. Different additive concentrations
[0100] In this example, the effect of the concentration of the additive in the mobile phase on the separation of isomers was also investigated. In an aqueous solution of 10 mM ammonium acetate, 0.01%, 0.025%, 0.05% and 0.1% ammonia water were added respectively, and clinical sample detection was performed according to the method of Example 1. The isomers of DCA and CDCA (ammonia concentration of 0.01%, 0.025%) and UDCA and interference peaks (ammonia concentration of 0.05%, 0.08%, 0.1%) were selected as monitoring objects, and the separation degree of DCA and CDCA, and the separation degree of UDCA and interference peaks were calculated to evaluate the optimal results. The specific results are shown in Table 8 and Figure 6 shown.
[0101] Table 8
[0102] Ammonia concentration 0.01% 0.025% 0.05% 0.08% 0.1% Separation 1.34 1.79 2.8 2.93 3.15
[0103] Table 8 and Figure 6 The results showed that when 0.01% ammonia was added to 10 mM ammonium acetate, the isomers DCA and CDCA could not meet the separation requirements ( Figure 6 B). When ammonia water with a concentration of more than 0.025% is added to 10 mM ammonium acetate, DCA and CDCA have a better separation effect ( Figure 6 A in the figure). The higher the concentration of ammonia water, the shorter the retention time. However, when the concentration of ammonia water is 0.1%, the separation degree between UDCA index and interference peak becomes smaller ( Figure 6 E), therefore, when 0.025-0.08% ammonia water is added to ammonium acetate, the isomers can meet the separation requirements, and the separation degree from the interference peak is large enough, and the concentration of ammonia water is preferably 0.05%.
[0104] Example 4 Effect of different eluent removal schemes on SPE nitrogen purge time
[0105] Bile acids are of many types and have complex chemical properties. In order to avoid the loss of the target and effectively extract the target, a high-concentration aqueous phase is generally used for elution, and a high-concentration organic phase is used for elution. However, the residual eluent components during the transition between the high-concentration aqueous eluent and the organic eluent cause the subsequent nitrogen blow-through step to take a long time, which is not conducive to the efficiency of batch detection. This example investigates the effects of different eluent removal schemes on the nitrogen blow-through time in the solid phase extraction step when pretreating the serum sample to be tested.
[0106] Different eluent removal schemes were used to process clinical samples, and the changes in nitrogen purge time were compared (the other processing steps were the same as the solid phase extraction SPE in the sample treatment in Example 1). The results are shown in Table 9.
[0107] Table 9
[0108] plan Directly wash off after rinsing After rinsing, dry with absorbent paper Centrifuge after washing After washing, dry with absorbent paper + centrifuge Nitrogen blowing time 120min 110min 90min 70min
[0109] The results in Table 9 show that the use of absorbent paper blotting + centrifugation to remove the eluent after elution can effectively shorten the nitrogen blow-through time.
[0110] Example 5 Effect of the cleaning procedure of the liquid chromatography tandem mass spectrometry system on the results
[0111] The liquid chromatography-tandem mass spectrometry system is a high-precision detection device with many pipelines in the equipment system. Due to the complexity of the biological specimen matrix, any residue in the pipeline may affect the test results, especially when the detection system is repeatedly used in large-scale experiments, it is easy to cause contamination of the chromatographic column and the detection instrument, resulting in elevated baselines, abnormal peak shapes, decreased detection sensitivity, etc., affecting the detection efficiency and accuracy. Conventional cleaning methods usually use pure water and a high proportion of organic solvents for a single cleaning, but because bile acid is a bisexual molecule that contains both hydrophilic hydroxyl and carboxyl or sulfonic acid groups and hydrophobic hydrocarbon cores and methyl groups, and the separation of multiple groups of isomers requires high system performance, it is impossible to completely guarantee the impact of residues produced by large-scale sample testing on its detection.
[0112] 1. Impact on Detection Accuracy
[0113] The system pipelines were cleaned using conventional cleaning schemes (using mobile phase A in Example 1 for cleaning) and the cleaning scheme in step 2 of Example 1 (85% water-15% methanol, 0.3 min / mL, 30 min-95% methanol, 0.4 min / mL, 20 min-80% isopropanol-20% water, 0.2 min / mL, 30 min-95% methanol, 0.4 min / mL, 15 min). The same batch of 4 samples were tested using the cleaned system (test conditions were the same as in Example 1) to examine the test effect (the spectrum was displayed using the isomers of DCA and CDCA). The test results are as follows: Figure 7 and Figure 8 shown.
[0114] After the system was cleaned with the conventional cleaning solution, three samples showed peak bifurcation and decreased response ( Figure 7 ), while the system cleaned by the cleaning scheme of the present invention was tested, and there was no peak bifurcation phenomenon in the four samples, the peak shape was better and the response was higher, and the quantification was more accurate ( Figure 8 ). Therefore, the cleaning solution of the present invention can effectively remove pipeline residues and ensure detection accuracy.
[0115] 2. Impact on chromatographic column life
[0116] After the system pipelines were cleaned using the cleaning scheme of step 2 of Example 1 and the conventional cleaning scheme (cleaning using mobile phase A of Example 1), the clinical sample test was performed using the method of Example 1, and the changes in the service life of the chromatographic column were statistically analyzed. The results of the number of times the chromatographic column was used are shown in Table 10.
[0117] Table 10
[0118] The cleaning scheme of the present invention Conventional cleaning solutions Chromatographic column needle times 4000 2500
[0119] The system cleaned by the conventional cleaning scheme has a chromatographic column life of 2500 needles (the current situation of the isomer target peak extension requires the change of the chromatographic column), while the system cleaned by the cleaning scheme of the present invention has a chromatographic column life of 4000 needles. Therefore, the cleaning scheme of the present invention can effectively remove impurities and significantly improve the life of the chromatographic column.
[0120] The above-mentioned embodiments only express several implementation methods of the present invention, and the descriptions thereof are relatively specific and detailed, but they cannot be understood as limiting the scope of the invention patent. It should be pointed out that, for ordinary technicians in this field, several variations and improvements can be made without departing from the concept of the present invention, and these all belong to the protection scope of the present invention. Therefore, the protection scope of the patent of the present invention shall be subject to the attached claims.
Claims
1. A method for detecting bile acid in serum, characterized in that: The following steps are involved: (1) Cleaning the system pipelines of liquid chromatography tandem mass spectrometry; (2) Pre-treating the serum sample to be tested and then performing liquid chromatography-tandem mass spectrometry detection; In the liquid chromatography tandem mass spectrometry detection, the mobile phase A of the liquid chromatography is: 8-12 mM ammonium acetate aqueous solution containing 0.025-0.08% ammonia water, and the mobile phase B is: 8-12 mM ammonium acetate acetonitrile solution containing 0.025-0.08% ammonia water.
2. The method for detecting bile acid in serum according to claim 1, characterized in that: In step (2), the volume concentration of ammonia water in the mobile phase A and the mobile phase B is 0.04% to 0.06%.
3. The method for detecting bile acid in serum according to claim 1, characterized in that: The pretreatment in step (2) includes the following steps: adding an internal standard precipitant and PBS buffer to the serum sample to be tested, centrifuging to obtain a supernatant; then subjecting the supernatant to solid phase extraction, centrifuging to obtain a supernatant, and filtering.
4. The method for detecting bile acid in serum according to claim 3, characterized in that: The solid phase extraction comprises the following steps: eluting with water, absorbing residual droplets at the bottom with absorbent paper, centrifuging again, eluting with methanol and then blowing with nitrogen.
5. The method for detecting bile acid in serum according to claim 4, characterized in that: The nitrogen blowing time is 65 to 75 minutes.
6. The method for detecting bile acid in serum according to claim 4, characterized in that: The centrifugal speed is 2500-3500 rpm, and the centrifugal time is 4-6 min.
7. The method for detecting bile acid in serum according to any one of claims 1 to 6, characterized in that: The chromatographic column of the liquid chromatography is a Phenomenex Kinetex EVO C18 chromatographic column.
8. The method for detecting bile acid in serum according to any one of claims 1 to 6, characterized in that: The elution procedure of the liquid chromatography is: 0.1 min, mobile phase B 25%; 4.5 min, mobile phase B 33%; 7.0 min, mobile phase B 99%; 8.5 min, mobile phase B 25%.
9. The method for detecting bile acid in serum according to any one of claims 1 to 6, characterized in that: In step (1), 10% to 18% methanol, 90% to 100% methanol, 75% to 85% isopropanol and 90% to 100% methanol are used in sequence to clean the system pipeline of the liquid chromatography tandem mass spectrometry.
10. The method for detecting bile acid in serum according to claim 9, characterized in that: 14% to 16% methanol, 94% to 96% methanol, 79% to 81% isopropanol and 94% to 96% methanol were used in sequence to clean the system pipeline of the liquid chromatography tandem mass spectrometry.
